A similar decrease in cytotoxicity was observed using anti-CD16 mAbs (39.06%±4.55 vs.1.94%±15.15% p = 0.04 U-test, Fig 4B) while a non-significant decrease was observed for NKG2C or NKG2D, In addition, a decreased total degranulation potential, as determined by maximal stimulation with PMA+ionomycin, was detected in COVID-19 patients (55.4 ±13,90% vs. 12.24 ±12.85%, p<0.01, U-test; Fig 4A and 4B) with conserved perforin contents comparable to HD (Fig 4C and 4D). Here, KLRK1 is linked to COVID-19.